August 2011

|
Volume 23 Issue 8
Aberrant Anatomy: You See What You Look For and You Look For What You Know
In this issue of the Journal of Invasive Cardiology, Pershad et al describe a case of a persistent sciatic artery.1 This is of course a well-described anomaly with an incidence of 0.025–0.05%.  It is commonly associated with aneurysm formation and ca…
Pulseless Right Groin… Bounding Distal Pulses
Unusual anatomic variants are rare and can sometimes mimic atherosclerotic peripheral vascular disease. In the case described, physical examination revealed a pulseless right groin yet palpable dorsalis pedis and posterior tibial pulses. During perip…
Percutaneous Closure of Aortocaval Fistula Using the Amplatzer Muscular VSD Occluder
ABSTRACT: Aortocaval fistula is an uncommon but often fatal complication of abdominal aortic aneurysm. Both open and endovascular repair of aortic aneurysm with aortocaval fistulae have been previously reported. We present the case of a patient with…
Long-Term Benefit Using DES in STEMI Patients
The current issue of the Journal of Invasive Cardiology addresses the ongoing debate of the future role of drug-eluting stents (DES) on ST-segment elevation myocardial infarction (STEMI) interventions, by presenting the most recent database reported…
Comparison of Six-Year Clinical Outcome of Sirolimus- and Paclitaxel-Eluting Stents to Bare-Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction: An Analysis of the RESEARCH and T-SEARCH Registries
Abstract: Background. Short- and long-term data showed that drug-eluting stents (DES) significantly decreased target vessel revascularization (TVR) and major adverse cardiac event (MACE) rates compared to bare-metal stents (BMS). However, conflicting…
Drug-Eluting or Bare-Metal Stents in ST-Elevation Myocardial Infarction: A Growing Dilemma or Closer to an Answer?
The decision of whether to implant a drug-eluting stent (DES) or bare-metal stent (BMS) in potentially the highest “risk” situation, primary percutaneous coronary intervention (pPCI) for acute ST-elevation myocardial infarction (STEMI), represents, i…
Long-Term Clinical Outcome in STEMI Patients Treated With Primary PCI and Drug-Eluting or Bare-Metal Stents: Insights from a High-Volume Single-Center Registry
Abstract: Objective. Use of drug-eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI) during routine primary percutaneous coronary intervention (pPCI) is controversial. Methods. From January 2004 to July 2008, a total of 2…
What is the Price for Perfection for Precise Aorto-Ostial Stent Placement?
Percutaneous coronary intervention (PCI) of an aorto-ostial lesion requires precise implantation of a coronary artery stent in order to prevent adverse clinical outcomes. “Geographic miss” occurs when the lesion is not fully covered or additional ste…
High Incidence of Inaccurate Stent Placement in the Treatment of Coronary Aorto-Ostial Disease
ABSTRACT: Objectives. The purpose of this study was to evaluate the incidence of inaccurate stent positioning in the treatment of coronary aorto-ostial lesions. Background. The percutaneous treatment of aorto-ostial disease is challenging, with a pau…
Routine Invasive Versus Ischemia-Guided Strategy in Patients with Acute Inferior ST-Elevation Myocardial Infarction who Received Fibrinolytic Therapy: A Prospective Randomized Controlled Pilot Trial
ABSTRACT: Aims. We sought to compare a routine invasive strategy of early coronary angiography and intended revascularization, with an ischemia-guided strategy in patients with acute inferior ST-elevation myocardial infarction (STEMI) who received fi…